Manuela Farris

ORCID: 0000-0001-5979-4413 · 6 papers in corpus · active 2008-2017

Study types

  • article 3
  • review 3

Condition tags

  • endometriosis 2
review 2017
·doi:10.1080/17512433.2017.1356718

Introduction: The pharmacodynamic effects of various combined oral estrogen-progestin combinations (COC) are examined for their components alone or in the various combined formulations. Special emphasis is given to products containing natur…

article 2014
·doi:10.1155/2014/815127

OBJECTIVE: Evaluate if different bleeding patterns associated with the use of the levonorgestrel intrauterine system (LNG-IUS) are associated with different uterine and endometrial vascularization patterns, as evidenced by ultrasound power …

review 2014
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.2014.914494

INTRODUCTION: Several selective progesterone receptor modulators (SPRMs) show promise in several areas of medicine and this work has been summarized by us in 2008. AREAS COVERED: Since the publication of our reviews, several developments h…

article 2011
·doi:10.1016/j.contraception.2011.01.020
review 2008
·doi:10.1358/dot.2008.44.12.1299292

The original form of hormonal contraception ("the Pill") has developed into a variety of modalities administered through different routes: oral, intramuscular, subcutaneous, transdermal, intrauterine or intravaginal, and intranasal (abandon…

article 2008
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.9.14.2473

BACKGROUND: Synthetic compounds can bind to progesterone receptors and these progesterone receptor ligands exhibit a spectrum of activities ranging from pure antagonism to a mixture of agonism and antagonism. These substances have been clas…